Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Volitionrx (VNRX) EPS (Weighted Average and Diluted) (2023 - 2025)

Volitionrx's EPS (Weighted Average and Diluted) history spans 4 years, with the latest figure at $0.0 for Q4 2025.

  • For Q4 2025, EPS (Weighted Average and Diluted) rose 104.07% year-over-year to $0.0; the TTM value through Dec 2025 reached $0.0, up 100.79%, while the annual FY2025 figure was $0.0, 100.44% up from the prior year.
  • EPS (Weighted Average and Diluted) reached $0.0 in Q4 2025 per VNRX's latest filing, up from -$0.05 in the prior quarter.
  • In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $0.0 in Q4 2025 to a low of -$0.12 in Q4 2023.
  • Average EPS (Weighted Average and Diluted) over 3 years is -$0.07, with a median of -$0.06 recorded in 2024.
  • The largest YoY upside for EPS (Weighted Average and Diluted) was 104.07% in 2025 against a maximum downside of 25.0% in 2025.
  • A 3-year view of EPS (Weighted Average and Diluted) shows it stood at -$0.12 in 2023, then skyrocketed by 50.86% to -$0.06 in 2024, then soared by 104.07% to $0.0 in 2025.
  • Per Business Quant, the three most recent readings for VNRX's EPS (Weighted Average and Diluted) are $0.0 (Q4 2025), -$0.05 (Q3 2025), and -$0.06 (Q2 2025).